Skip to content

ICAAC: New treatment for lipid problems shows promise in HIV patients

Premature to say atazanavir not linked to fat loss, says lipodystrophy expert

Neurological side-effects of efavirenz mild and transient, study claims

Hospitalisations and deaths down in US, slight increase in number of admissions due to liver problems

Bone problems caused by HIV and duration of anti-HIV treatment

Tenofovir doesn't harm growth of kids' bones, suggests small study

Infection with harmless hepatitis G doesn't mean that HIV treatment works better

TMC125 is safe and effective in patients with NNRTI resistance

Study of nucleoside-sparing regimens stopped early due to high failure rates; NRTIs likely to remain therapeutic backbone for the time being